Like any product destined for human ingestion, Cannabis is thoroughly studied from seed to sale. A long list of compliance practices exists for producers and distributors to understand and excel at every stage.
Just as in food production, not every CBD supplier is made equally. Inferior sources of biomass or inefficient practices at any production stage can make for an inferior product.
Due to standardized practices, compliant and legally sold cannabis products are safe and effective for medical and recreational use. However, wherever these standards exist, Abundant Labs goes beyond. We are proud to be an industry leader in innovation, quality, and excellent methods. Below are a few points that allow us to stand apart and offer genuinely exceptional products and how a lesser product may compare.
Building clinical products means examining the farm-to-distillate process closely to avoid any harmful biochemicals tagging along. This examination raises concerns about using pesticides, herbicides, and other chemical additives for plant products. While these practices may increase yields, they do so at the cost of quality. A good product begins with sourcing clean biomass from reputable farmers who excel at their craft without harmful chemicals.
Abundant Labs sources from farmers who provide clean biomass with exceptional and unique properties. Our product is received fresh so that we may begin the distillation process with as little loss of delicate oil as possible.
Maintaining the delicate properties which make cannabis so varied and unique is one of the most pressing challenges regarding CBD producers. Rushing any step of the process or using lesser extraction technologies will result in a product with less impact and character.
Our equipment ensures an extraction temperature below -90ºC, allowing for consistent and efficient extraction. A balance of low temperatures and centrifugal force is part of what sets our process apart.
As a blanket practice, the 2018 Farm Bill allowed for the production, possession, and sale of CBD products so long as they do not contain over 0.03% THC content. This is the benchmark for all legal CBD products distilled in the domestic market. Lesser products will include a higher percentage of THC, compromising the drug’s intended effects. This has been especially dangerous for those who are screened for THC in the workplace.
Abundant Labs exceeds purity by controlling product makeup down to the molecular level. Our Broad Spectrum CBD Distillation process is beneficial for users seeking the synergistic effects of cannabinoids present in hemp but want options for removing particular cannabinoids. This targeted approach is especially important for clients with little experience with hemp extract or sensitivity to certain cannabinoids.
Beyond the end product, considerations must be made for the cleanliness of the facility, management practices, and employee fairness. A reputable supplier excels not only in what they put out but what they put in. For this reason, Abundant Labs proudly displays our cGMP certification.
cGMP certification ensures procedures, technologies, and systems are up-to-date to comply with Federal regulations and that the correct techniques and equipment are in place to prevent contamination and errors that may affect consumers. cGMP systems include a series of controls for quality-focused operations, including management systems, quality raw materials, standard operating procedures, detecting and investigating deviations, and reliable analytical testing.
As you can see, not all CBD products are created equally. If you have further questions about the process or quality of our products, please drop us a line. Education and good information is key to building a stronger cannabis community, and we look forward to connecting further with you.